Biosecurity Market Size, Share, and Industry Analysis, By Offering (Product {Disinfection & Decontamination Products, Physical Biosecurity & Access Control Products, PPE & Consumables, and Others} and Services), By End-user (Government & Public Health Agencies, Farms & Producer Organizations, Hospitals & Laboratories, Pharmaceutical & Biotechnology Companies, and Others), and Regional Forecast till 2034

The global biosecurity market was valued at USD 18.42 billion in 2025. The market is projected to grow from USD 19.66 billion in 2026 to USD 33.33 billion by 2034, exhibiting a CAGR of 6.8% during the forecast period.

Biosecurity includes preventive, physical, procedural, diagnostic, and surveillance measures used to reduce the risk of introduction, spread, or release of harmful biological agents across farms, laboratories, healthcare facilities, public health systems, food supply chains, and critical infrastructure. For instance, the World Health Organization’s (WHO) updated laboratory biosecurity guidance emphasizes risk assessment, governance, institutional biosafety committees, information security, cybersecurity, and measures to prevent lapses involving high-consequence biological materials. These factors are anticipated to support the market expansion over the forthcoming years.

Biosecurity Market Driver

Rising Frequency of Zoonotic and Transboundary Animal Disease Outbreaks to Drive Market Growth

The increasing global spread of zoonotic and transboundary diseases is driving the demand for farm-level biosecurity, animal disease surveillance, decontamination, diagnostics, and emergency preparedness programs. Avian influenza remains one of the most vital diseases, as outbreaks affect poultry production, wildlife, trade, farmer livelihoods, and public health preparedness.

• For instance, the FAO’s (Food and Agriculture Organization of the United Nations) May 2026 global avian influenza update highlighted the continuing worldwide occurrence of avian influenza viruses with zoonotic potential. FAO also stated that avian influenza is among the most important transboundary animal diseases affecting poultry, wildlife, and occasionally humans.

Download Free sample to learn more about this report.

In February 2025, the U.S. Department of Agriculture (USDA) announced a USD 1.0 billion strategy to combat highly pathogenic avian influenza, including USD 500.0 million for biosecurity measures, USD 400.0 million for affected farmers, and USD 100.0 million for vaccine research and related actions.

Biosecurity Market Restraint

Fragmented Implementation and High Compliance Burden to Hamper Market Growth

Biosecurity adoption varies significantly by region, farm size, laboratory capacity, and public health infrastructure. Small farms and resource-limited laboratories often face cost and training barriers in implementing structured biosecurity protocols. Moreover, compliance requires continuous behavior change, staff training, audits, cleaning/disinfection protocols, access control, diagnostics, and documentation, which can limit adoption in low-resource settings, thereby hindering market growth in the forthcoming years.

Biosecurity Market Opportunity

Digital Biosecurity, One Health Surveillance, and Risk-based Farm Programs to Offer Growth Opportunity

In the upcoming years, the growing integration of digital monitoring, risk assessment tools, disease surveillance, environmental sensors, traceability platforms, and One Health frameworks is expected to create lucrative opportunities. Biosecurity is moving beyond disinfectants and PPE toward data-driven prevention programs that combine diagnostics, farm audits, animal movement control, wildlife risk assessment, and outbreak response planning.

Segmentation

Key Insights

The report covers the following key insights:

• Advancement in Biosecurity Products
• Overview of Guidelines for Biosecurity
• Key Industry Developments - Partnerships, Mergers, Acquisitions, and Others

Analysis by Offering

By offering, the market is segmented into product and services. The product segment is further subdivided into disinfection & decontamination products, physical biosecurity & access control products, PPE & consumables, and others.

The product segment is expected to hold the largest share of the global biosecurity market during the forecast period. This is mainly due to the recurring demand for disinfectants, decontamination products, PPE, diagnostic kits, sampling products, access-control systems, biosecurity software, and other consumables used across animal farms, laboratories, healthcare facilities, and public health settings.

Analysis by End-user

Based on end-user, the market is divided into government & public health agencies, farms & producer organizations, hospitals & laboratories, pharmaceutical & biotechnology companies, and others.

The government & public health agencies segment is expected to dominate the market over the forecast period. This is due to the central role of national and regional agencies in disease surveillance, outbreak preparedness, border biosecurity, emergency response, food and animal health protection, and laboratory biosecurity governance.

Regional Analysis

Request for Customization   to gain extensive market insights.

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for a 40.2% share of the global biosecurity market in 2025. The market expansion is supported by government funding, strong livestock disease preparedness programs, advanced laboratory infrastructure, and high awareness among commercial producers.

Asia Pacific is expected to record the highest CAGR over the forecast period. The market growth is due to large livestock populations, growing poultry and swine production, rising zoonotic disease risk, and strengthening public health surveillance infrastructure.

• For instance, according to data reported by the China Feed Industry Association, broiler feed production in the country grew by 0.5% in the first half of 2024.

Key Players Covered

The global biosecurity market is moderately fragmented, with key companies competing significantly across products and services. Strategically, companies are focusing on portfolio expansion, acquisitions, integrated product-service offerings, and more to gain significant market share in the coming years.

The report includes the profiles of the following key players:

• Neogen Corporation (U.S.)
• BIOMÉRIEUX (France)
• IDEXX Laboratories, Inc. (U.S.)
• DeLaval (Sweden)
• Merck Animal Health (U.S.)
• Thermo Fisher Scientific Inc.(U.S.)
• LANXESS (Germany)
• Ecolab Inc. (U.S.)
• Better Biosecurity LLC. (S.)
• Betagro Public Company Limited (Thailand)

Key Industry Developments

• June 2026: Imperial launched a novel Biosecurity Network of Excellence to tackle growing threats to human, animal, and plant health at a landmark conference.
• November 2025: Lanxess introduced several new biosecurity solutions for the Indian market at the 2025 Poultry India Expo.